Background Governments and international donors have partnered to provide free HIV
treatment to over 6 million individuals in low and middle-income countries. Understanding …

Background Today's uncertain HIV funding landscape threatens to slow progress towards
treatment goals. Understanding the costs of antiretroviral therapy (ART) will be essential for …

Objectives To report on the cost of medical care for HIV‐infected patients stratified by CD4
cell count for a regional population over a 9‐year period, and to examine the effect of …

Background: Many African countries are rapidly expanding HIV/AIDS treatment programs.
Empirical information on the cost of delivering antiretroviral therapy (ART) for HIV/AIDS is …

Background Through delayed HIV disease progression, highly active antiretroviral therapy
(HAART) may reduce direct medical costs, thus at least partially offsetting therapy costs …

Background Given the size of the HIV epidemic in South Africa and other developing
countries, scaling up antiretroviral treatment (ART) represents one of the key public health …

Background In economic analyses of HIV interventions, South Africa is often used as a case
in point, due to the availability of good epidemiological and programme data and the global …

Objective We estimated the average annual cost per patient of ART per facility (unit cost) in
Nigeria, described the variation in costs across facilities, and identified factors associated …

Differentiated service delivery models provide an opportunity to reduce the cost of HIV
treatment while increasing the focus on advanced patients. Also, stable patients who need …

Methods: We calculated observed per-person-per-year (ppy) costs of streamlined care in 17
health facilities in SEARCH Study intervention communities (NCT: 01864603) via micro …